Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
The recently emerged COVID-19 disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has adversely affected the whole world. As a significant public health threat, it has spread worldwide. Scientists and global health experts are collaborating to find and execute speedy diagnostics, robust and highly effective vaccines, and therapeutic techniques to tackle COVID-19. The ocean is an immense source of biologically active molecules and/or compounds with antiviral-associated biopharmaceutical and immunostimulatory attributes. Some specific algae-derived molecules can be used to produce antibodies and vaccines to treat the COVID-19 disease. Algae have successfully synthesized several metabolites as natural defense compounds that enable them to survive under extreme environments. Several algae-derived bioactive molecules and/or compounds can be used against many diseases, including microbial and viral infections. Moreover, some algae species can also improve immunity and suppress human viral activity. Therefore, they may be recommended for use as a preventive remedy against COVID-19. Considering the above critiques and unique attributes, herein, we aimed to systematically assess algae-derived, biologically active molecules that could be used against this disease by looking at their natural sources, mechanisms of action, and prior pharmacological uses. This review also serves as a starting point for this research area to accelerate the establishment of anti-SARS-CoV-2 bioproducts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 The putative association between ACE2 shedding after SARS-CoV-2 infection. Reprinted from Viana et al. [56] with permission from Elsevier. Copyright 2021, Elsevier. License Number: 4993920853888.](https://figures.cochat.ai/paper-figures/5a210fbc15f54785af3e5e68483d9cb7/algae-derived-bioactive-molecules-for-the-potential-treatment-of-sars-cov-2-figure-2.jpg)

![Figure 4 An array of algae-based antioxidants. The inner circle shows the diversity of biologically active antioxidants produced in a marine environment. The outer circle represents their novel therapeutic and biomedical potentialities. Reprinted from Bilal and Iqbal [101] with permission from Elsevier. Copyright 2021 Elsevier B.V. License Number: 4982940408845.](https://figures.cochat.ai/paper-figures/f5c156ddf96d45948304802cdef5e2ec/algae-derived-bioactive-molecules-for-the-potential-treatment-of-sars-cov-2-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other active compounds in microalgae such as astaxanthin from green microalga Haematococcus pluvialis and sulfated polysaccharides from red microalga Porphyridium sp. additionally possess antiviral properties (Alam et al., 2021).”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Alam et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · cited 1×
“TMPRSS2 (a human serine protease) is responsible for priming the S-glycoprotein of SARS-CoV-2, and the human angiotensin-converting enzyme 2 (hACE2) is engaged as a receptor for the entry of SARS-CoV-2 [83].”
BackgroundCryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897 · cited 1×
“[82] reported that the S-glycoprotein of SARS-CoV-2 contains 66 glycosylation sites.”
BackgroundRole of gut microbiota in type 2 diabetes pathophysiology
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,708 · cited 1×
“Gut microbiome dysbiosis, which is known for the resultant alterations of gut microbiota, has also been shown as related to several diseases and disorders, such as depression [52], obesity [53], IBS [54], and type-2 diabetes [55].”
BackgroundCoronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707 · cited 2×
“The red algae-derived high-mannose-binding lectin of 121 amino acids (namely, Griffithsin (GRFT)) is reported to inhibit SARS-CoV entry by specifically binding to the spike glycoprotein [37,39].”
BackgroundCheung, K. S., Hung, I. F. N., Chan, P. P. Y., Lung, K. C., Tso, E., Liu, R., Ng, Y. Y., Chu, M. Y., Chung, T. W. H., Tam, A. R., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.065 · Cited by 1,631 · cited 1×
“Approximately 20% of patients with SARS-CoV-2 exhibit GI problems, as reported by a Hong Kong cohort study [46].”
BackgroundSite-specific glycan analysis of the SARS-CoV-2 spike
Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S., & Crispin, M. (2020) · Science · doi:10.1126/science.abb9983 · Cited by 1,548 · cited 1×
“Another study [81] has been performed to identify the location of 22 glycosylation sites, where glycans are attached to the SARS-CoV-2 spike and form sugar at each site.”
BackgroundAlterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Zuo, T., Zhang, F., Lui, G. C. Y., Yeoh, Y. K., Li, A. Y. L., Zhan, H., Wan, Y., Chung, A. C. K., Cheung, C. P., Chen, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.048 · Cited by 1,537 · cited 2×
“This study also found that patients with COVID-19 have higher levels of the harmful microbes Actinomyces viscosus, Bacteroides nordii, and Clostridium hathewayi and lower levels of the friendly microbes Faecalibacterium prausnitzii, Lachnospiraceae bacterium, Eubacterium rectale, Ruminococcus obeum, and Dorea formicig…”
ResultGastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
Lin, L., Jiang, X., Zhang, Z., Huang, S., Zhang, Z., Fang, Z., Gu, Z., Gao, L., Shi, H., Mai, L., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321013 · Cited by 924 · cited 1×
“Another study analyzed 95 patients with this virus [47].”
BackgroundGut microbiota and Covid-19- possible link and implications
Dhar, D., & Mohanty, A. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198018 · Cited by 608 · cited 1×
“Nevertheless, a healthy gut microbiome is crucial for its supportive role in antiviral immunity [50], and improving gut flora by maintaining a nutritional diet is essential for strengthening the gut microbiota to attenuate the effect of novel SARS-CoV-2 [51].”
BackgroundOxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection
Delgado-Roche, L., & Mesta, F. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.04.019 · Cited by 604
Research works printed but not linked: 3
- 2014, Antiviral activity of an aqueous extract from the red alga Laurencia obtusa against influenza A and B viruses, Rev. Cuba. Med. Trop., 66, 273
- Sundararaj, 2020, Algae: A potential source to prevent and cure the novel coronavirus–A review, Int. J. Emerg. Technol., 11, 479
- Nikunj, 2020, Lensi P, Richa P, haresh P, Red algae derived phycocompounds as an inhibitors of SARS-CoV-2, J. Interdiscip. Cycle Res., 12, 662
Cited by
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
Seaweed Components as Potential Modulators of the Gut Microbiota
Shannon, E., Conlon, M., & Hayes, M. (2021) · Marine Drugs · doi:10.3390/md19070358 · Cited by 157
“The potential bioactivity of seaweed components has been demonstrated previously in in vitro studies [35,36], however the impact of gastrointestinal enzymatic digestion and colonic bacterial fermentation in vivo must also be considered, since it may have an effect on the bioavailability of prebiotic and other actives…”
BackgroundBioactive compounds by microalgae and potentials for the management of some human disease conditions
Eze, C. N., Chukwu, K. O., Ihim, S. A., Ayoka, T. O., Aduba, C. C., Ndukwe, J. K., Nwaiwu, O., & Onyeaka, H. N. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023004 · Cited by 124
Cyanobacteria and microalgae in supporting human habitation on Mars
Mapstone, L. J., Leite, M. N., Purton, S., Crawford, I. A., & Dartnell, L. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107946 · Cited by 92
“Other active compounds in microalgae such as astaxanthin from green microalga Haematococcus pluvialis and sulfated polysaccharides from red microalga Porphyridium sp. additionally possess antiviral properties (Alam et al., 2021).”
Evaluation of Microalgae Antiviral Activity and Their Bioactive Compounds
Carbone, D. A., Pellone, P., Lubritto, C., & Ciniglia, C. (2021) · Antibiotics · doi:10.3390/antibiotics10060746 · Cited by 95
Metadata
- Authors
- Alam, M. A., Parra-Saldivar, R., Bilal, M., Afroze, C. A., Ahmed, M. N., Iqbal, H. M. N., & Xu, J.
- Affiliations
- Zhengzhou University (CN)
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey 64849, Mexico
- Huai'an University (CN)
- University of Development Alternative (BD)
- Biotechnology & Natural Medicine Division, TechB Nutrigenomics, Dhaka 1209, Bangladesh
- Tecnológico de Monterrey (MX)
- Corresponding author
- Iqbal, Hafiz M.N.
- Xu, Jingliang
- ORCID
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-04-08
- Volume
- 26
- Issue
- 8
- Pages
- 2134
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8068085
- OpenAlex
- W3147076663
- Cited by
- 69
- References
- 116
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 7 · 2023: 13 · 2022: 31 · 2021: 6
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Consejo Nacional de Ciencia y Tecnología (735340, CVU: 735340)
- Sistema Nacional de Investigadores (CVU: 735340, 735340)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
- Keywords
- SARS-CoV-2, COVID-19 pandemic, antiviral activity, marine bioproducts
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Phaeophyceae, Chlorophyta, Rhodophyta, Antiviral Agents, Carrageenan, Humans, Polysaccharides, Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2. https://app.cochat.ai/papers/10.3390/molecules26082134
- The paper
- Alam, M. A., Parra-Saldivar, R., Bilal, M., Afroze, C. A., Ahmed, M. N., Iqbal, H. M. N., & Xu, J. (2021). Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2. Molecules. https://doi.org/10.3390/molecules26082134
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.